In many natural and clinical settings, bacteria are associated with some type of biotic or
abiotic surface that enables them to form biofilms, a multicellular lifestyle with bacteria …

Bacteria can form biofilms in natural and clinical environments on both biotic and abiotic
surfaces. The bacterial aggregates embedded in biofilms are formed by their own produced …

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Chronic biofilm‐associated infections caused by Staphylococcus aureus often lead to
significant increases in morbidity and mortality, particularly when associated with indwelling …

The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …

Staphylococcus aureus is a major cause of nosocomial and community-acquired infections
and represents a significant burden on the healthcare system. S. aureus attachment to …

Biofilms are communities of microbial cells that underpin diverse processes including
sewage bioremediation, plant growth promotion, chronic infections and industrial biofouling …

Increasing attention has been focused on understanding bacterial biofilms and this growth
modality's relation to human disease. In this review we explore the genetic regulation and …

Exopolysaccharide is a key part of the extracellular matrix that contributes to important
mechanisms of bacterial pathogenicity, most notably biofilm formation and immune evasion …

Antibiotic resistance and biofilm-forming capacity contribute to the success of
Staphylococcus aureus as a human pathogen in both healthcare and community settings …